Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.00097 | 1 |
mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.00085 | 1 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |
mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00049 | 1 |
mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.00084 | 1 |
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.00048 | 1 |
mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.00044 | 1 |